Search Results 51-60 of 14779 for anti-TNF drugs

1. A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy - Mayo Clinic

   * Must have failed anti-TNF treatment for HS. * To be eligible for the Sub-study, participants must be naïve to biologic therapy for treatment of HS.

2. Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year - Mayo Clinic

   The purpose of this study is to compare the efficacy of treatment with ustekinumab or adalimumab in biologic naive participants with moderately-to-severely ...

3. Adalimumab-Afzb (Subcutaneous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects.

4. Tocilizumab (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

   This medicine helps keep joint damage from getting worse after other medicines (eg, adalimumab, etanercept, infliximab) have been used and did not work well. It ...

5. Adalimumab-Aaty (Subcutaneous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects.

6. A Study of the Effectiveness and Safety of Vedolizumab Compared to Adalimumab for Participants with Ulcerative Colitis - Mayo Clinic

   The purpose of this study is to evaluate the effectiveness and safety of vedolizumab intravenous (IV) treatment compared to adalimumab subcutaneous (SC) ...

7. Hidradenitis suppurativa - Diagnosis and treatment - Mayo Clinic

   Two are the tumor necrosis factor inhibitors adalimumab, or Humira, and infliximab, or Remicade. These medicines work by dampening part of the immune system ...

8. Health care maintenance in patients with IBD - Mayo Clinic

   For example, patients who are receiving combination therapy with anti-TNF agents and an immunosuppressive drug have a blunted response to the pneumococcal ...

9. Immunosuppressive Drugs Clinical Trials - Mayo Clinic Research

   The purpose of this study is to compare the efficacy of treatment with ustekinumab or adalimumab in biologic naive participants with moderately-to-severely ...

10. Mayo Clinic Q&A podcast Dr. Faubion IBD

    drugs begin to affect the immune system body wide, okay. ... All of these affect TNF, we call them anti TNF. ... Does it traffic to the colon or not, the so-called ...